DRREDDY vs SUNPHARMA: Stock Comparison
SUN PHARMACEUTICAL IND L is the larger company by market capitalisation. DR. REDDY S LABORATORIES shows a lower P/E, while SUN PHARMACEUTICAL IND L shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
DRREDDY leads 5; SUNPHARMA leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | DRREDDY | SUNPHARMA |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | DRREDDY | SUNPHARMA |
|---|---|---|
| Live Price | ₹1,177 | ₹1,913.3 |
| Day Change | -0.42% | 0.73% |
| Volume | 10.44 L | 11.08 L |
| 52-Week High | ₹1,414.9 | ₹2,046.9 |
| 52-Week Low | ₹1,101 | ₹1,548 |
| Distance from 52W High | -16.81% | -6.53% |
Valuation
| Metric | DRREDDY | SUNPHARMA |
|---|---|---|
| Market Cap | ₹98,254 Cr | ₹4.59 L Cr |
| P/E Ratio | 30.43x | 37.7x |
| P/B Ratio | 2.59x | 5.46x |
| EPS | ₹4.85 | ₹4.65 |
| Book Value | ₹460.31 | ₹348.31 |
| Dividend Yield | 0.67% | 0.83% |
Growth
| Metric | DRREDDY | SUNPHARMA |
|---|---|---|
| Revenue Growth (TTM YoY) | -11.6% | 12.8% |
| EPS Growth (TTM YoY) | -86.2% | 25.6% |
| Qtr Sales Growth | -36.58% | -62.48% |
| Qtr Profit Growth | -7.09% | -61.56% |
Profitability & Leverage
| Metric | DRREDDY | SUNPHARMA |
|---|---|---|
| ROE | 10.27% | 13.72% |
| ROCE | 9.14% | 15.12% |
| Net Margin | 12.76% | 18.56% |
| Operating Margin | 21.43% | 26.44% |
| Debt to Equity | 0.17x | 0.05x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | DRREDDY | SUNPHARMA |
|---|---|---|
| Promoter Holding | 26.64%▲ 0.01 pp | 54.48% |
| FII Holding | 32.07%▼ 1.01 pp | 14.53%▼ 1.4 pp |
| DII Holding | 31.74%▲ 1.02 pp | 22.18%▲ 1.07 pp |
| Public Holding | 9.35%▲ 0.02 pp | 8.81%▲ 0.33 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DR. REDDY S LABORATORIES and SUN PHARMACEUTICAL IND L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.